Covid-19: AstraZeneca, After Rebuke, Releases New Data Supporting Its Vaccine - The New York Times
Disgruntled AstraZeneca sues former executive Luke Miels for jumping to GlaxoSmithKline post | Fierce Pharma
AstraZeneca Canadian Business Centre | WZMH Architects
AstraZeneca - Review of Drug Manufacturer
AstraZeneca R&D Centre and Corporate Headquarters, Cambridge, UK
AstraZeneca Unveils a New Headquarters in Cambridge | 2021-11-28 | Architectural Record
AstraZeneca in United States
Gothenburg - AstraZeneca
AstraZenecas Strategic R&D Centre and Global HQ, Cambridge - Herzog & de Meuron | Arquitectura Viva
Working at AstraZeneca
AstraZeneca to buy Boston biotech Alexion for $39 billion in rare-disease push - The Boston Globe
AstraZeneca's HQ budget balloons to 3 times original forecast | Fierce Biotech
AstraZeneca in United States
AstraZeneca in Canada
AstraZeneca in Japan
AstraZeneca Plans New R&D Center And Alexion Headquarters | Contract Pharma
AstraZeneca R&D Centre and Corporate Headquarters, Cambridge, UK
AstraZeneca Lab and Office Facility - HOK
AstraZeneca Seroquel whistleblower suit diminished but preserved by federal judge | Fierce Pharma
Why Disclosure Policies Don't Discourage Academe's Drug Salesmen
Contact Us
AstraZeneca opens new R&D base in Cambridge, England
AstraZeneca to open major research center in Kendall Square - The Boston Globe
